Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...
Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...
2don MSN
Zealand Pharma seeks to challenge GLP‑1 dominance with obesity drug aimed at long‑term use
Zealand Pharma plans to launch five obesity and related drugs by 2030 as the Danish company tries to break into the lucrative ...
MedPage Today on MSN
GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients
GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...
US Weekly on MSN
‘Love Is Blind’ Alum Irina Solomonova Reveals GLP-1 Use: ‘This Isn’t a Quick Fix Thing for Me’
Love Is Blind alum Irina Solomonova has been using a GLP-1 to slim down. “I’m finishing my first month on GLP-1s. I’m on ...
The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...
Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...
We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...
With the skyrocketing popularity of GLP-1 RAs, some lesser-known side effects, including anemia, are coming to light.
The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...
College students may plan an appointment during winter break and inquire about GLP-1 medications. What should a primary care ...
The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results